De-Escalation of Antiplatelet Therapy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Clinical Trials.
Babikir KheiriMohammed OsmanAhmed AbdallaAdam ChahineSahar AhmedKhansa OsmanGhassan BachuwaMustafa HassanDeepak L BhattPublished in: Journal of cardiovascular pharmacology and therapeutics (2018)
Our results suggest a net clinical benefit of de-escalation therapy shortly after PCI, without increased risk of MACE. Larger randomized trials will be necessary to confirm these findings.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- acute coronary syndrome
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- coronary artery disease
- open label
- coronary artery bypass grafting
- coronary artery bypass
- atrial fibrillation
- heart failure
- stem cells
- smoking cessation
- cell therapy
- clinical trial
- double blind